Dr James Shannon
Dr Shannon joined Immodulon in 2015 bringing his experience of clinical development and regulatory experience to the Immodulon Board. Dr Shannon has 30 years’ experience working across a number of senior positions in the pharmaceutical industry.
Previous roles include Chief Medical Officer at GlaxoSmithKline and Global Head of Drug Development for Novartis. In Dr Shannon’s roles at GlaxoSmithKline and Novartis, he was very involved in bringing highly innovative oncology products to the market. He has also served on the boards of a number of smaller biopharmaceutical companies. He is trained in Medicine and Cardiology, received undergraduate and graduate degrees at Queen's University Belfast and is a member of the Royal College of Physicians (UK).